The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCELERON PHARMA INC | COM | 00434H108 | 220,906 | 1,760,346 | SH | SOLE | 1,760,346 | 0 | 0 | ||
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 4,390 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| BEAM THERAPEUTICS INC | COM | 07373V105 | 16,344 | 126,985 | SH | SOLE | 126,985 | 0 | 0 | ||
| BRIDGEBIO PHARMA INC | COM | 10806X102 | 20,532 | 336,817 | SH | SOLE | 336,817 | 0 | 0 | ||
| ESSA PHARMA INC | COM NEW | 29668H708 | 5,958 | 208,524 | SH | SOLE | 208,524 | 0 | 0 | ||
| FATE THERAPEUTICS INC | COM | 31189P102 | 29,154 | 335,918 | SH | SOLE | 335,918 | 0 | 0 | ||
| GENERATION BIO CO | COM | 37148K100 | 289 | 10,738 | SH | SOLE | 10,738 | 0 | 0 | ||
| INHIBRX INC | COM | 45720L107 | 6,205 | 225,480 | SH | SOLE | 225,480 | 0 | 0 | ||
| INTELLIA THERAPEUTICS INC | COM | 45826J105 | 301,141 | 1,859,926 | SH | SOLE | 1,859,926 | 0 | 0 | ||
| KEROS THERAPEUTICS INC | COM | 492327101 | 4,425 | 104,186 | SH | SOLE | 104,186 | 0 | 0 | ||
| RELAY THERAPEUTICS INC | COM | 75943R102 | 4,383 | 119,775 | SH | SOLE | 119,775 | 0 | 0 | ||
| VERVE THERAPEUTICS INC | COM | 92539P101 | 6,207 | 103,013 | SH | SOLE | 103,013 | 0 | 0 | ||